Global Brain Imaging Devices Market Projected to Reach USD 7.77 Billion by 2032, Driven by Rising Neurological Disorders and AI-Powered Innovations, states DelveInsight

Leading Brain Imaging Devices companies are Siemens Healthineers, GE HealthCare, Koninklijke Philips N.V., Canon Medical Systems, Hitachi High-Tech Corporation, Fujifilm Holdings, Samsung Electronics, Shimadzu Corporation, Esaote SPA, Mediso Ltd., United Imaging Healthcare, Hyperfine, PerkinElmer, MR Solutions and others.
The global brain imaging devices market is set for strong and sustained growth, increasing from USD 5,091.71 million in 2024 to USD 7,779.85 million by 2032, according to the latest analysis by DelveInsight. The market is forecast to expand at a compound annual growth rate (CAGR) of 5.50% during 2025-2032, fueled by rising prevalence of neurological disorders, rapid technological advancements such as artificial intelligence (AI) and machine learning (ML), and robust product development activities by leading medical device companies.

DelveInsight's Brain Imaging Devices Market Report 2032 provides in-depth analysis of market size, forecasts, segmentation, competitive dynamics, and recent technological developments. Covering regions across North America, Europe, Asia-Pacific, and Rest of the World, it delivers critical insights for manufacturers, investors, healthcare providers, and policymakers navigating this evolving landscape.

Download DelveInsight's Brain Imaging Devices Market Report 2032 to explore market growth drivers, AI-powered innovations, and regional opportunities shaping the future of neuroimaging @ Global Brain Imaging Devices Market [https://www.delveinsight.com/report-store/brain-imaging-devices-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=apr]

Growing Need for Advanced Brain Imaging Technologies

The global burden of neurological disorders-including Alzheimer's disease, Parkinson's disease, epilepsy, stroke, multiple sclerosis, and brain tumors-is intensifying. Aging populations, coupled with lifestyle-related risk factors such as obesity, stress, and cardiovascular disease, are contributing to the increased incidence of these conditions. As accurate diagnosis and continuous monitoring remain critical to effective treatment, brain imaging devices like MRI, CT, and PET scanners are indispensable in clinical and research settings.

For instance, MRI enables early detection of Alzheimer's-related brain shrinkage, while CT and PET scans play crucial roles in stroke detection, tumor visualization, and treatment monitoring. This growing patient pool underscores the demand for advanced neuroimaging solutions worldwide.

Technological Breakthroughs Reshaping the Brain Imaging Devices Market

Artificial intelligence and machine learning are revolutionizing neuroimaging. AI-powered tools are enhancing diagnostic precision, automating workflows, and reducing reporting times, making imaging more accessible and efficient. From detecting subtle abnormalities to predicting disease progression, these tools are driving earlier interventions and more personalized care.

For example, AI-integrated MRI and PET systems can now identify amyloid and tau protein deposits-critical biomarkers for Alzheimer's disease. Companies such as Philips, GE HealthCare, Siemens Healthineers, and Hyperfine are leading the charge by integrating advanced AI features into their imaging platforms.

The introduction of portable MRI systems, hybrid PET/MRI platforms, and low-dose CT technologies has further expanded the scope of neuroimaging. These devices improve accessibility, particularly in underserved regions, and reduce patient exposure to radiation, enhancing both safety and efficiency.

Get access to expert forecasts, segmentation analysis, and competitive intelligence to guide your strategic decisions in the USD 7.77 billion brain imaging devices market [https://www.delveinsight.com/sample-request/brain-imaging-devices-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=apr].

Brain Imaging Devices Market Segmentation and Key Insights

The brain imaging devices market is structured across product type, portability, application, end-user, and geography, offering significant opportunities across multiple segments:

* Brain Imaging Devices Market By Product Type - The devices segment dominated in 2024, accounting for nearly 80% of the market share. MRI leads due to its superior contrast resolution and radiation-free imaging. Advanced functional MRI (fMRI) applications, including neural activity mapping and pre-surgical planning, further strengthen its dominance.
* Brain Imaging Devices Market By Portability - Stationary imaging systems (MRI, CT, PET) remain the gold standard, widely adopted in hospitals and diagnostic centers. Their ability to handle high patient volumes and provide high-resolution scans ensures continued growth.
* Brain Imaging Devices Market By Application - The brain tumor segment held the largest share in 2024, as rising tumor incidence drives demand for precise imaging in diagnosis, treatment planning, and ongoing monitoring.
* Brain Imaging Devices Market By End-User - Hospitals dominate the end-user landscape, equipped with state-of-the-art imaging infrastructure and specialized radiologists. Their role as key centers for advanced diagnostics and clinical trials strengthens their market position.

Learn how AI, portable MRI, and hybrid PET/MRI platforms are transforming patient care and fueling market expansion. Request your complimentary report preview today @ Brain Imaging Devices Market Growth Factors and Dynamics [https://www.delveinsight.com/report-store/brain-imaging-devices-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=apr]

Brain Imaging Devices Regional Market Outlook

* North America Brain Imaging Devices Market

Accounting for 41% of the global market in 2024, North America remains the dominant region, supported by strong R&D investments, advanced healthcare infrastructure, and high disease prevalence. In the U.S. alone, more than 7.5 million people were living with Alzheimer's disease, a figure projected to nearly double by 2050. Leading companies continue to launch AI-enabled imaging platforms tailored for neurological care, reinforcing the region's leadership.

* Europe Brain Imaging Devices Market

Europe is witnessing robust growth, driven by rising Alzheimer's, dementia, and stroke cases. Favorable reimbursement frameworks, EU-funded neuroscience initiatives, and rapid adoption of AI-powered imaging platforms are shaping the region's neuroimaging landscape.

* Asia-Pacific Brain Imaging Devices Market

Projected to be the fastest-growing Brain Imaging Devices market with a CAGR of 6.87% (2025-2032), Asia-Pacific is benefiting from rapid healthcare investment, expanding hospital infrastructure, and increasing awareness about brain health. China, Japan, and India are key contributors, with Japan leading in advanced adoption of MRI and PET systems, while China is boosting domestic manufacturing to enhance affordability and access.

Brain Imaging Devices Competitive Landscape

The market remains consolidated, with global medtech giants and emerging innovators shaping competition. Key Brain Imaging Devices companies include:

* Siemens Healthineers, GE HealthCare, Koninklijke Philips N.V., Canon Medical Systems, Hitachi High-Tech Corporation, Fujifilm Holdings, Samsung Electronics, Shimadzu Corporation, Esaote SPA, Mediso Ltd., United Imaging Healthcare, Hyperfine, PerkinElmer, and MR Solutions.

These players dominate through extensive product portfolios, continuous R&D investment, and global distribution networks. Startups and niche firms are complementing the landscape by focusing on portable devices, AI-powered diagnostic software, and wearable EEG/MEG systems.

Leverage DelveInsight's in-depth market research to identify growth hotspots, evolving technologies, and key players leading the neuroimaging revolution @ Brain Imaging Devices Companies and Manufacturers [https://www.delveinsight.com/sample-request/brain-imaging-devices-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=apr]

Recent collaborations and acquisitions are reshaping the industry:

* Hyperfine partnered with NVIDIA in 2025 to strengthen AI integration in its FDA-cleared Swoop Registered Portable MRI system.
* Canon Medical Systems acquired NordicNeuroLab, expanding its advanced neuroimaging portfolio.
* Philips partnered with Mayo Clinic on AI-powered neuroimaging research.

Brain Imaging Devices Market Challenges

Despite strong growth, the market faces notable challenges. The high cost of advanced imaging equipment limits adoption among smaller hospitals and diagnostic centers, particularly in emerging economies. Additionally, concerns about radiation exposure from CT and PET remain, especially for patients requiring repeated scans. These factors highlight the importance of ongoing innovation in low-dose technologies, portable imaging solutions, and cost-effective systems.

Impact of AI and Tariff Policies in Brain Imaging Devices Market

AI is expected to play a transformative role across clinical, research, and tele-radiology applications, reducing diagnostic errors and improving global access to neuroimaging. At the same time, U.S. tariffs on medical device imports are influencing manufacturing costs, potentially impacting adoption rates. While this presents challenges, it also encourages domestic innovation and localized sourcing strategies among global medtech leaders.

Download the Brain Imaging Devices Market Report and equip your team with data-backed insights to capture opportunities across North America, Europe, Asia-Pacific, and beyond @ Brain Image Devices Competitive Landscape [https://www.delveinsight.com/sample-request/brain-imaging-devices-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=apr]

Brain Imaging Devices Market Future Outlook

The brain imaging devices market is poised for strong expansion through 2032, driven by:

* Increasing neurological disease prevalence worldwide.
* Continuous technological innovation, particularly AI and hybrid imaging.
* Expanding access through portable and low-field MRI systems.
* Strategic partnerships, acquisitions, and investments that accelerate R&D and market reach.

As neuroimaging becomes increasingly central to precision medicine, early diagnostics, and personalized treatments, demand for advanced brain imaging technologies will continue to rise across both developed and emerging healthcare systems.

About DelveInsight

DelveInsight is a leading business consulting and market research firm focused on life sciences. With expertise spanning pharmaceutical, biotechnology, and medical device industries, DelveInsight provides comprehensive market insights, competitive intelligence, pipeline analysis, and strategic advisory services. Our reports equip clients with actionable intelligence to make informed business decisions and capitalize on emerging opportunities.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=global-brain-imaging-devices-market-projected-to-reach-usd-777-billion-by-2032-driven-by-rising-neurological-disorders-and-aipowered-innovations-states-delveinsight]
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/consulting/primary-research-services

Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com



This release was published on openPR.